<bill session="109" type="h" number="4392" updated="2013-07-19T19:43:07-04:00">
  <state datetime="2005-11-18">REFERRED</state>
  <status>
    <introduced datetime="2005-11-18"/>
  </status>
  <introduced datetime="2005-11-18"/>
  <titles>
    <title as="introduced" type="official">To provide for the importation of pharmaceutical products under a compulsory license as provided for under the World Trade Organization.</title>
  </titles>
  <sponsor id="400007"/>
  <cosponsors>
    <cosponsor id="400050" joined="2005-12-08"/>
    <cosponsor id="400069" joined="2006-04-06"/>
    <cosponsor id="400080" joined="2005-12-13"/>
    <cosponsor id="400100" joined="2006-04-06"/>
    <cosponsor id="400120" joined="2005-12-16"/>
    <cosponsor id="400126" joined="2006-01-31"/>
    <cosponsor id="400162" joined="2005-12-08"/>
    <cosponsor id="400227" joined="2005-12-16"/>
    <cosponsor id="400289" joined="2006-05-03"/>
    <cosponsor id="400357" joined="2005-12-08"/>
    <cosponsor id="400387" joined="2005-12-13"/>
  </cosponsors>
  <actions>
    <action datetime="2005-11-18">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E2424-2425"/>
    </action>
    <action state="REFERRED" datetime="2005-11-18">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Foreign trade and international finance"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Health"/>
    <term name="Import restrictions"/>
    <term name="Imports"/>
    <term name="Intellectual property"/>
    <term name="International affairs"/>
    <term name="International agencies"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Patents"/>
    <term name="Public health"/>
    <term name="Trade agreements"/>
  </subjects>
  <amendments/>
  <summary>11/18/2005--Introduced.
Requires the U.S. Trade Representative to inform the General Council of the World Trade Organization (WTO) that the United States: (1) declares itself an eligible importing member for the purpose of being able to import pharmaceutical products pursuant to the Decision of the General Council of August 30, 2003, on "Implementation of paragraph six of the Doha Declaration on the TRIPS Agreement and public health;" and (2) withdraws its name from the list contained in the "General Council Chairperson's Statement" accompanying such Decision, of countries that voluntarily relinquished the right to import pharmaceutical products manufactured under compulsory licenses. Authorizes the President to import pharmaceutical products manufactured under a compulsory license to meet public health needs or to address situations of inadequate supply caused by insufficient domestic manufacturing capacity, in accordance with the Decision. Subjects such imported pharmaceutical products to the Federal Food, Drug, and Cosmetic Act.</summary>
</bill>
